Differential Epigenetic Effects of BMI Inhibitor PTC-028 on Fusion-Positive Rhabdomyosarcoma Cell Lines from Distinct Metastatic Sites is a research paper published in Regenerative Engineering and Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
national institutes of health
Grant: K08-7K08CA194162-02
National Institutes of Health
Grant: 7K08CA194162-02
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas
FWCI
0.32
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals